As our study has found that JAK1/STAT3 signaling pathway is essential for the growth and development of femoral trochlea in PI, the JAK inhibition may hold promise in reversing bone loss and attenuating TD. The gene discussed is STAT3; the disease is thanatophoric dysplasia.